References
- Hendlin D, Stapley E O, Jackson M, Wallick H, Miller A K, Wolf F J, Miller T W, Chaiet L, Kahan F M, Foltz E L, Woodruff H B, Mata J M, Hernandez S, Mochales S. Phosphonomycin, a new antibiotic produced by strains of Streptomyces. Science 1969; 166: 122–123
- Kahan F M, Kahan J S, Cassidy P J, Kropp H. The mechanism of action of fosfomycin (phosphomycin). Ann NY Acad Sci 1974; 235: 364–365
- Forsgren A, Walder M. Antimicrobial activity of fosfomycin in vitro. J Antimicrob Chemother 1983; 11: 467–471
- Werner H, Krasemann C, Hammann R, Ungerechts J. In-vitro-Untersuchungen über die kombinierte Einwirkung von Fosfomycin und Metronidazol auf Anaerobier. Terapiewoche 1981; 31: 5496–5500
- Miettinen P, Lahtinen J, Ristkari S, Alhava E M, Antila S, Härkönen N, Päkkönen M, Mokka R. Antibiotic prophylaxis in elective colorectal surgery. Fosfomycin-metronidazole vs cefuroxime-metronidazole in 371 patients. Gastroenterol Intern Suppl 1988; 1(Abs No 794)
- Andåker L, Höjer H, Kihlström E, Lindhagen J. Stratified duration of prophylactic antimicrobial treatment in emergency abdominal surgery. Metronidazole-fosfomycin versus metronidazole-gentamicin in 381 patients. Acta Chir Scand 1987; 153: 59–64
- Andåker L, Burman L G, Eklund A, Graffner H, Hansson J, Hellberg R, Höjer H, Ljungqvist U, Kjellgren K, Kling P A, Krook H, Lindhagen J, Molin K. Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. Eur J Surg 1992; 158: 181–185
- Walder M, Leandoer L, Törnqvist A, Forsgren A. Long-term effects on bacterial sensitivity patterns of preoperative antibiotic prophylaxis in colorectal surgery. Scand J Infect Dis Suppl 1988; 53: 59–64
- Tsuruoka T, Yamada Y. Characterization of spontaneous fosfomycin (Phosphonomycin)-resistant cells of Escherichia coli B in vitro. J Antibiot 1975; 11: 906–911
- Cordaro J C, Melton T, Stratis J P, Atagun M, Gladding C, Hartman P E, Roseman S. Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate: sugar phosphotransferase genes of Salmonella typhimurium. J Bacteriol 1976; 128: 785–793
- Dulaney E L, Ruby C L. In vitro development of resistance to fosfomycin. J Antibiot 1977; 3: 252–261
- Alper M D, Ames B N. Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: positive selection of Salmonella typhimurium cya and crp mutants. J Bacteriol 1978; 133: 149–157
- Baquero F, López-Brea M, Valls A, Cañedo. Fosfomycin and plasmidic resistance. Chemotherapy 1977; 23: 133–140
- Wiedemann B. Development of fosfomycin-resistant Enterobacteriaceae. Proceedings of the 10th International Congress of Chemotherapy, W Siegenthaler. The American Society for Microbiology, Washington DC 1978; 1
- Kurashige S, Yamaguchi N, Hiraishi H, Teshima C, Mitsuhashi S. Decrease in the virulence of fosfomycin-resistant Salmonella enteritidis strains. Microbial drug resistance, S Mitsuhashi, H Hashimoto. Univ. Park Press, Baltimore 1974; 535
- Curtiss R, III, Kelly S M, Gulig P A, Gentry-Weeks C R, Galán J E. Avirulent salmonellae expressing virulence antigens from other pathogens for use as orally administered vaccines. Virulence mechanisms of bacterial pathogens, J Roth. American Society for Microbiology, Washington 1988; 311
- Navas J, García-Lobo J M, León J, Ortíz J M. Structural and functional analyses of the fosfomycin resistance transposon Tn2921. J Bacteriol 1985; 162: 1061–1067
- Villar C J, Hardisson C, Suárez J E. Cloning and molecular epidemiology of plasmid-determined fosfomycin resistance. Antimicrob Agents Chemother 1986; 29: 309–314
- Llaneza J, Villar C J, Salas J E, Suarez J E, Suarez J E, Mendoza M C, Hardisson C. Plasmid-mediated fosfomycin resistance is due to enzymatic modification of the antibiotic. Antimicrob Agents Chemother 1985; 28: 163–164
- León J, García-Lobo J M, Navas J, Ortiz J M. Fosfomycin-resistant plasmids determine an intracellular modification of fosfomycin. J Gen Microbiol 1985; 131: 1649–1655